Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Brief Report

Clinical Outcomes of Young Black Men Receiving HIV Medical Care in the United States, 2009–2014

Chowdhury, Pranesh, MD, MPH; Beer, Linda, PhD; Shouse, R. Luke, MD, MPH; Bradley, Heather, PhD for the Medical Monitoring Project

JAIDS Journal of Acquired Immune Deficiency Syndromes: May 1, 2019 - Volume 81 - Issue 1 - p 5–9
doi: 10.1097/QAI.0000000000001987
Epidemiology
Buy
SDC

Background: More than one-quarter of 2016 HIV diagnoses among blacks in the United States occurred among persons aged 15–24 years, and three-quarters were among men. Although the prevalence of viral suppression in all tests in the past 12 months (durable viral suppression) among persons receiving HIV care increased from 58% to 68% during 2009–2013, we do not know whether this same improvement was observed among young black men receiving care.

Methods: We analyzed the 2009–2014 Medical Monitoring Project data collected from 336 black men aged 18–24 years. We estimated the proportion of young black men receiving HIV care who were prescribed antiretroviral therapy (ART), adherent to ART, and durably virally suppressed. We assessed changes in clinical outcomes over time and their association with patient characteristics, health behaviors, and depression.

Results: During 2009–2014, 80% of young black men receiving HIV care were prescribed ART, 73% were adherent to ART, and 36% had durable viral suppression. There was no significant change in viral suppression over this period. ART prescription and durable viral suppression were significantly higher among those receiving the Ryan White HIV/AIDS Program assistance compared with those who did not. Durable viral suppression was significantly lower among those who used drugs compared with those who did not.

Conclusions: Viral suppression among young black men during 2009–2014 was lower than that among the overall population receiving HIV care in 2013 (36% vs. 68%). Increasing viral suppression is essential to improve health and reduce HIV transmissions in this key population.

Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA.

Correspondence to: Pranesh P. Chowdhury, MD, MPH, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E-46, Atlanta, GA 30329 (e-mail: cnu1@cdc.gov).

Supported by the Centers for Disease Control and Prevention.

Presented in part at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI); March 4–7, 2018; Boston, Massachusetts.

The authors have no conflicts of interest to disclose.

The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Received August 21, 2018

Accepted January 16, 2019

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.